Publications by authors named "David Warshal"

Claim this Profile
C
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, David P Warshal

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol.
Koji Matsuo, Danielle M Enserro, Jason D Wright, Lynda D Roman, Matthew A Powell, David P Warshal

Gynecol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pembrolizumab and lenvatinib in the treatment of recurrent ovarian carcinoma: A single institution experience.
Helen Toma, Rebeca Kelly, Chelsea Katz, Hannah Hong, Hannah Diasti, David P Warshal

Gynecol Oncol Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, David P Warshal

Gynecol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278).
Allan Covens, Helen Q Huang, Bradley J Monk, Yong-Beom Kim, Moon-Hong Kim, David Warshal

Gynecol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of physical function and quality of life before and after nonradical surgical therapy for stage IA1 and IA2-IB1 cervical cancer (GOG-0278).
Jeanne Carter, Helen Q Huang, Bradley J Monk, Yong-Beom Kim, Moon-Hong Kim, David Warshal

Gynecol Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.
Daniela E Matei, Danielle M Enserro, Marcus E Randall, David Mutch, William Small, David Warshal

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Aine Clements, Danielle Enserro, Kyle C Strickland, Rebecca Previs, Daniela Matei, David Warshal

Gynecol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Natural Epigenetic Therapies in 3D Ovarian Cancer and Patient-Derived Tumor Explants: New Avenues in Regulating the Cancer Secretome.
Rebeca Kelly, Diego Aviles, Catriona Krisulevicz, Krystal Hunter, Lauren Krill, David Warshal

Biomolecules· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of the "BRCA Quality Improvement Dissemination Program": An initiative to improve patient receipt of cancer genetics services at five health systems.
Erica M Bednar, Minxing Chen, Michael T Walsh, Amanda L Eppolito, Molly H Klein, David P Warshal

Gynecol Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implementation and outcome evaluations of a multi-site improvement program in cancer genetics.
Erica M Bednar, Blake Harper, Michael T Walsh, Ruth Rechis, Michelle Bilbao, David Warshal

J Genet Couns· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase III Trial of Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Patients With Carcinosarcoma of the Uterus or Ovary: An NRG Oncology Trial.
Matthew A Powell, Virginia L Filiaci, Martee L Hensley, Helen Q Huang, Kathleen N Moore, David P Warshal

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Therapy Augments Classic Chemotherapy in Suppressing the Growth of 3D High-Grade Serous Ovarian Cancer Spheroids over an Extended Period of Time.
Michelle Bilbao, Chelsea Katz, Stephanie L Kass, Devon Smith, Krystal Hunter, David Warshal

Biomolecules· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can Cannabidiol Affect the Efficacy of Chemotherapy and Epigenetic Treatments in Cancer?
Courtney Griffiths, James Aikins, David Warshal, Olga Ostrovsky

Biomolecules· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin and Paclitaxel for Advanced Endometrial Cancer: Final Overall Survival and Adverse Event Analysis of a Phase III Trial (NRG Oncology/GOG0209).
David S Miller, Virginia L Filiaci, Robert S Mannel, David E Cohn, Takashi Matsumoto, David P Warshal

J Clin Oncol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral ovarian micrometastatic adenocarcinoma upon prophylactic oophorectomy concurrent with low anterior resection for rectal cancer.
Robin Irons, Erin McIntosh, Alexandre Hageboutros, David Warshal, Steven McClane

World J Surg Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II evaluation of ixabepilone in the treatment of recurrent/persistent carcinosarcoma of the uterus, an NRG Oncology/Gynecologic Oncology Group study.
Carolyn K McCourt, Wei Deng, Don S Dizon, Heather A Lankes, Michael J Birrer, David Warshal

Gynecol Oncol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
Peter G Rose, James J Java, Mark A Morgan, Angeles Alvarez-Secord, Joshua P Kesterson, David P Warshal

Gynecol Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of nab-paclitaxel in the treatment of recurrent or persistent advanced cervix cancer: A gynecologic oncology group study.
David S Alberts, John A Blessing, Lisa M Landrum, David P Warshal, Lainie P Martin

Gynecol Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 evaluation of irofulven as second-line treatment of recurrent or persistent intermediately platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group trial.
Russell J Schilder, John A Blessing, Mark S Shahin, David S Miller, Krishnansu Sujata Tewari, David P Warshal

Int J Gynecol Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study.
Amy D Tiersten, Michael W Sill, Danielle Knight, Franco Muggia, Agustin A Garcia, David P Warshal

Gynecol Oncol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II evaluation of weekly gemcitabine and docetaxel for second-line treatment of recurrent carcinosarcoma of the uterus: a gynecologic oncology group study.
Brigitte E Miller, John A Blessing, Frederick B Stehman, Mark S Shahin, S Diane Yamada, David P Warshal

Gynecol Oncol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between ERBB2 amplification and progression-free survival and overall survival in advanced stage, suboptimally-resected epithelial ovarian cancers: a Gynecologic Oncology Group Study.
John Farley, Sartoru Fuchiuji, Kathleen M Darcy, Chunqiao Tian, William J Hoskins, David Warshal

Gynecol Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in cervical carcinoma limited to the pelvis: a phase I/II study of the Gynecologic Oncology Group.
Paul A DiSilvestro, Joan L Walker, Astrid Morrison, Peter G Rose, Howard Homesley, David Warshal

Gynecol Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis